These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 17063269)

  • 41. Differential effects of various progestogens on metabolic risk factors for breast cancer.
    Campagnoli C; Abbà C; Ambroggio S; Lotano MR; Peris C
    Gynecol Endocrinol; 2007 Oct; 23 Suppl 1():22-31. PubMed ID: 17943536
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hormone therapy: maximizing the benefits.
    Heikkinen J
    Gynecol Endocrinol; 2006 Mar; 22(3):160-2. PubMed ID: 16835079
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hormone therapy and colorectal cancer.
    Fenton A; Panay N
    Climacteric; 2009 Apr; 12(2):89-90. PubMed ID: 19259852
    [No Abstract]   [Full Text] [Related]  

  • 44. [Cancer and HRT--"now when the dust has settled"].
    Krøll J
    Ugeskr Laeger; 2004 Apr; 166(15-16):1465-6. PubMed ID: 15146821
    [No Abstract]   [Full Text] [Related]  

  • 45. Reduction in proliferation with six months of letrozole in women on hormone replacement therapy.
    Fabian CJ; Kimler BF; Zalles CM; Khan QJ; Mayo MS; Phillips TA; Simonsen M; Metheny T; Petroff BK
    Breast Cancer Res Treat; 2007 Nov; 106(1):75-84. PubMed ID: 17221152
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [A United States National Institutes of Health investigation suspended due to risk of breast cancer with use of hormone replacement in menopause].
    Zárate-Treviño A
    Gac Med Mex; 2002; 138(6):595-6. PubMed ID: 12532629
    [No Abstract]   [Full Text] [Related]  

  • 47. 9 facts everyone should know about breast cancer.
    Baron RH; Walsh A
    Am J Nurs; 1995 Jul; 95(7):29-33. PubMed ID: 7604861
    [No Abstract]   [Full Text] [Related]  

  • 48. Menopausal hormone therapy after breast cancer.
    Chlebowski RT; Col N
    Lancet; 2004 Feb; 363(9407):410-1. PubMed ID: 14962515
    [No Abstract]   [Full Text] [Related]  

  • 49. Do risks of hormone therapy persist after discontinuation?
    J Fam Pract; 2008 Jun; 57(6):366, 369. PubMed ID: 18677802
    [No Abstract]   [Full Text] [Related]  

  • 50. Commentary: hazards of studying women: the oestrogen oestrogen/progesterone dilemma.
    Kuller LH
    Int J Epidemiol; 2004 Jun; 33(3):459-60. PubMed ID: 15166203
    [No Abstract]   [Full Text] [Related]  

  • 51. [Did the decrease in use of menopausal hormone therapy induce a decrease in the incidence of breast cancer in France (and elsewhere)?].
    Ringa V; Fournier A
    Rev Epidemiol Sante Publique; 2008 Oct; 56(5):297-301. PubMed ID: 18947946
    [No Abstract]   [Full Text] [Related]  

  • 52. Does the progesterone receptor genetic polymorphism +331G/A hPR influence the risk of venous thromboembolism among postmenopausal women using hormone therapy? The ESTHER Study.
    Bouaziz E; Canonico M; Verstuyft C; Carcaillon L; Martin F; Scarabin PY; Guiochon-Mantel A;
    Maturitas; 2009 Oct; 64(2):136-8. PubMed ID: 19782484
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Hormone therapies and ovarian cancer].
    Grenman S; Salmi T
    Duodecim; 2002; 118(4):349-56. PubMed ID: 12233039
    [No Abstract]   [Full Text] [Related]  

  • 54. Alcohol use, with hormone therapy, may increase breast cancer risk.
    Mayo Clin Womens Healthsource; 2006 May; 10(5):3. PubMed ID: 16585921
    [No Abstract]   [Full Text] [Related]  

  • 55. [Hormone replacement therapy and cancer risk].
    Nierwetberg D; Schmidt M; Kimmig R
    MMW Fortschr Med; 2008 Oct; 150(43):27-8. PubMed ID: 19031580
    [No Abstract]   [Full Text] [Related]  

  • 56. Type and duration of exogenous hormone use affects breast cancer histology.
    Kumar AS; Cureton E; Shim V; Sakata T; Moore DH; Benz CC; Esserman LJ; Hwang ES
    Ann Surg Oncol; 2007 Feb; 14(2):695-703. PubMed ID: 17103262
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Membrane-initiated effects of progesterone on proliferation and activation of VEGF in breast cancer cells.
    Neubauer H; Adam G; Seeger H; Mueck AO; Solomayer E; Wallwiener D; Cahill MA; Fehm T
    Climacteric; 2009 Jun; 12(3):230-9. PubMed ID: 19340614
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Is HRT justified for symptom management in women at higher risk of developing breast cancer?
    Rippy L; Marsden J
    Climacteric; 2006 Dec; 9(6):404-15. PubMed ID: 17085372
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The World Health Organization defines hormone replacement therapy as carcinogenic: is this plausible?
    Mueck AO; Seeger H
    Gynecol Endocrinol; 2008 Mar; 24(3):129-32. PubMed ID: 18335326
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cancer issues.
    Marsden J; Sturdee D
    Best Pract Res Clin Obstet Gynaecol; 2009 Feb; 23(1):87-107. PubMed ID: 19036643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.